Table 2.
Completed study per protocol | 55 (50.5 %) |
Refused further treatment | 20 (18.3 %) |
• Unacceptable side effects | 9 (8.3 %) |
• Reason not given | 7 (6.4 %) |
• Non-compliant | 2 (1.8 %) |
• Patient choice | 2 (1.8 %) |
Adverse event | 25 (22.9 %) |
Disease progression | 1 (0.9 %) |
Alternate treatment | 1 (0.9 %) |
Other medical problems | 2 (1.8 %) |
Other | 5 (4.6 %) |